Abstract
This Special Communication discusses the Food and Drug Administration's (FDA's) proposed rule that would limit N-nitrosonornicotine (NNN) levels in smokeless tobacco products. It argues that finalising and implementing this first 'product standard' would mark a significant step forward in the FDA's efforts to reduce tobacco-related harms.
Original language | English (US) |
---|---|
Pages (from-to) | 352-354 |
Number of pages | 3 |
Journal | Tobacco control |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2018 |
Bibliographical note
Publisher Copyright:© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Keywords
- Non-cigarette tobacco products
- harm reduction
- public policy